Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rxo (RXO) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $168.5 million.

  • Rxo's Shares Outstanding (Diluted Average) rose 2627.2% to $168.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $168.5 million, marking a year-over-year increase of 2627.2%. This contributed to the annual value of $168.5 million for FY2025, which is 2627.2% up from last year.
  • Rxo's Shares Outstanding (Diluted Average) amounted to $168.5 million in Q4 2025, which was up 2627.2% from $168.6 million recorded in Q3 2025.
  • In the past 5 years, Rxo's Shares Outstanding (Diluted Average) ranged from a high of $168.6 million in Q3 2025 and a low of $115.0 million during Q3 2021
  • Its 5-year average for Shares Outstanding (Diluted Average) is $130.3 million, with a median of $119.4 million in 2023.
  • In the last 5 years, Rxo's Shares Outstanding (Diluted Average) tumbled by 180.28% in 2024 and then skyrocketed by 4334.35% in 2025.
  • Over the past 5 years, Rxo's Shares Outstanding (Diluted Average) (Quarter) stood at $115.2 million in 2021, then increased by 0.55% to $115.8 million in 2022, then increased by 3.17% to $119.5 million in 2023, then rose by 11.68% to $133.4 million in 2024, then rose by 26.27% to $168.5 million in 2025.
  • Its last three reported values are $168.5 million in Q4 2025, $168.6 million for Q3 2025, and $168.5 million during Q2 2025.